Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial

被引:0
|
作者
Inoue, Takashi [1 ]
Akashi, Kenichi [2 ]
Fujita, Retsu [3 ]
Kimura, Ayako [2 ]
Watanabe, Masako [2 ]
Ida, Hiroyuki [1 ]
Ohashi, Yasuo [3 ]
Katsunuma, Toshio [2 ]
机构
[1] Jikei Univ, Sch Med, Pediat, Tokyo, Japan
[2] Jikei Univ, Sch Med, Pediat, Daisan Hosp, Tokyo, Japan
[3] Univ Tokyo, Sch Hlth Sci & Nursing, Biostat Epidemiol & Prevent Hlth Sci, Tokyo, Japan
关键词
Air pollution; Asthma; -; management; Environment;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
3418
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
    Jeffrey L. Cummings
    Kate Zhong
    Jefferson W. Kinney
    Chelcie Heaney
    Joanne Moll-Tudla
    Abhinay Joshi
    Michael Pontecorvo
    Michael Devous
    Anne Tang
    James Bena
    Alzheimer's Research & Therapy, 8
  • [2] Dapiglutide for Obesity - A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
    Nielsen, Casper Kjaesgaard
    Palsson, Thorir
    Jensen, Benjamin
    Johansen, Nicklas
    Pedersen, Miriam
    Forman, Julie
    Lund, Asger
    Knop, Filip Krag
    OBESITY, 2024, 32 : 182 - 182
  • [3] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
    Cummings, Jeffrey L.
    Zhong, Kate
    Kinney, Jefferson W.
    Heaney, Chelcie
    Moll-Tudla, Joanne
    Joshi, Abhinay
    Pontecorvo, Michael
    Devous, Michael
    Tang, Anne
    Bena, James
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [4] Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial
    Hobbs, Adrian J.
    Moyes, Amie J.
    Baliga, Reshma S.
    Ghedia, Dipa
    Ochiel, Rachel
    Sylvestre, Yvonne
    Dore, Caroline J.
    Chowdhury, Kashfia
    Maclagan, Kate
    Quartly, Harriet L.
    Sofat, Reecha
    Smit, Angelique
    Schreiber, Benjamin E.
    Coghlan, Gerry J.
    MacAllister, Raymond J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (09) : 1251 - 1267
  • [5] Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial
    Marsman, Diane E.
    den Broeder, Nathan
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    van der Maas, Aatke
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E758 - E766
  • [6] Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Leslie M.
    Blauwet, Mary Beth
    Tracy, Katherine
    Cai, Na
    Walzer, Mark
    Blahunka, Paul
    Marek, Gerard J.
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 3355 - 3369
  • [7] Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
    Marvin R. McCreary
    Patrick M. Schnell
    Dale A. Rhoda
    Scientific Reports, 12
  • [8] Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
    McCreary, Marvin R.
    Schnell, Patrick M.
    Rhoda, Dale A.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Ricardo Alexandre Toniolo
    Michelle Silva
    Francy de Brito Ferreira Fernandes
    José Antonio de Mello Siqueira Amaral
    Rodrigo da Silva Dias
    Beny Lafer
    Journal of Neural Transmission, 2018, 125 : 247 - 257
  • [10] A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Toniolo, Ricardo Alexandre
    Silva, Michelle
    Ferreira Fernandes, Francy de Brito
    de Mello Siqueira Amaral, Jose Antonio
    Dias, Rodrigo da Silva
    Lafer, Beny
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (02) : 247 - 257